A Study to Evaluate the Immunogenicity Composed of Four Vaccine Strains in a Live Influenza Vaccine in Children

2014-07-24 14:06:47 | BioPortfolio


The primary objective of this study is to demonstrate the immunologic noninferiority of a separate vaccine to FluMist in children 2 to 17 years of age.


The primary objective of this study is to demonstrate the immunologic noninferiority of a quadrivalent vaccine to FluMist in children 2 to 17 years of age by comparing the post dose strain-specific GMTs of serum HAI antibody.

Study Design

Allocation: Randomized, Control: Active Control, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment




Q/LAIV, FluMist-Y b, FluMist-V b


Radiant Research
United States


Active, not recruiting


MedImmune LLC

Results (where available)

View Results


Published on BioPortfolio: 2014-07-24T14:06:47-0400

Clinical Trials [61 Associated Clinical Trials listed on BioPortfolio]

Safety Study of FluMist With and Without Ampligen

The purpose of this study is to evaluate FluMist with and without Ampligen in healthy volunteers.

Assessing Choice in the Employer Setting (ACES) Study

The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or TIV in the employer setting when compared to a control g...

LAIV (Flumist®) Administration in CF Patients

Influenza (the "flu") is one of the most common respiratory viruses associated with respiratory deteriorations in children and adolescents with cystic fibrosis. These deteriorations usuall...

Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants

- Primary objective is to demonstrate equivalent immunogeniticity of CAIV-T and FluMist - Secondary objective of this study is to assess the safety and tolerability of CAIV-T com...

A Study to Evaluate the Immunogenicity of MEDI3250 in Adults 18 to 49 Years of Age

The objective of this study is to prove that MEDI3250 is at least as effective as two different forms the vaccine, FluMist, by comparing the specific events after dosage.

PubMed Articles [4429 Associated PubMed Articles listed on BioPortfolio]

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season.

Intranasally administered live attenuated influenza vaccine (LAIV) was initially licensed in the United States in 2003 as a trivalent formulation (LAIV3) (FluMist, MedImmune, LLC). Quadrivalent live a...

Colonization Limits Efficacy, but Not Immunogenicity, of Live-Attenuated Influenza Virus Vaccine and Enhances Pathogenesis After Influenza Challenge.

Intranasally administered live-attenuated influenza virus (LAIV) vaccines provide significant protection against heterologous influenza A virus (IAV) challenge. However, LAIV administration can modify...

Cross- immunity of a H9N2 live attenuated influenza vaccine against H5N2 highly pathogenic avian influenza virus in chickens.

The most commonly utilized inactivated influenza vaccines (IIVs) are usually deficient in cross immunity against divergent viruses. On the other hand, live attenuated influenza vaccines (LAIVs) are pr...

Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site.

The development of viral vector vaccines against various pathogens for which conventional vaccination approaches are not applicable has been a priority for a number of years. One promising approach is...

The effect of pre-existing immunity on virus detection and immune responses in a phase II randomized trial of a Russian-backbone live attenuated influenza vaccine in Bangladeshi children.

In a 2012 phase II clinical trial (NCT01625689), 300 Bangladeshi children aged 24 to 59 months with no prior influenza vaccine exposure were randomized to receive a single dose of intra-nasally admini...

Medical and Biotech [MESH] Definitions

Healthy People Programs are a set of health objectives to be used by governments, communities, professional organizations, and others to help develop programs to improve health. It builds on initiatives pursued over the past two decades beginning with the 1979 Surgeon General's Report, Healthy People, Healthy People 2000: National Health Promotion and Disease Prevention Objectives, and Healthy People 2010. These established national health objectives and served as the basis for the development of state and community plans. These are administered by the Office of Disease Prevention and Health Promotion (ODPHP). Similar programs are conducted by other national governments.

Governmental guidelines and objectives pertaining to public food supply and nutrition including recommendations for healthy diet and changes in food habits to ensure healthy diet.

Surgical reinnervation of a denervated peripheral target using a healthy donor nerve and/or its proximal stump. The direct connection is usually made to a healthy postlesional distal portion of a non-functioning nerve or implanted directly into denervated muscle or insensitive skin. Nerve sprouts will grow from the transferred nerve into the denervated elements and establish contact between them and the neurons that formerly controlled another area.

Process of evaluating the health of a patient and determining if they are healthy enough for surgery.

Dietary patterns which have been found to be important in reducing disease risk.

More From BioPortfolio on "A Study to Evaluate the Immunogenicity Composed of Four Vaccine Strains in a Live Influenza Vaccine in Children"

Quick Search


Relevant Topics

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Searches Linking to this Trial